Director Klinck buys 14,000 CDLX shares at $3.49; holdings +26.1%; cluster of 3 insider buys in 14 days amid -82.6% decline from 52-week high.
Director John L. Klinck Jr. purchased 14,000 shares of Cardlytics at $3.49 on 2024-08-12, increasing his holdings by 26.1% to 67,593 shares post-transaction. This buy occurs in a cluster context: 2 other insiders also purchased within the past 14 days. The timing is notable given that the stock trades at $35.20, representing -82.6% from its 52-week high of $202.50, and the company reported a net loss of $-4.3M against quarterly revenue of $69.6M. The multi-insider purchase pattern in a sharply depressed environment warrants attention to whether this reflects management's assessment of intrinsic value relative to the 52-week range.